Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,302 papers from all fields of science
Search
Sign In
Create Free Account
Ganciclovir:MCnc:Pt:XXX:Qn
Known as:
???????????:????????:??????:XXX:?????
, Ganciclovir [Mass/volume] in Unspecified specimen
, ????:????:???:XXX:???
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Ganciclovir
Unit of Mass Concentration
XXX Unspecified
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Absorption enhancement effect of piperine and chitosan on ganciclovir sol-id lipid nanoparticles: formulation, optimization and invivo pharmacoki-netics
M. RavindraBabu
,
P. RaviPrakash
,
N. Devanna
International Journal of Research in…
2019
Corpus ID: 156033043
The purpose of the present study was to formulate Solid Lipid Nanoparticles (SLNs) of Ganciclovir (GCV) in combination with…
Expand
2013
2013
Intravitreal Ganciclovir for Neonatal Cytomegalovirus-Associated Retinitis: A Case Report
A. Oschman
,
V. Murthy
,
R. Kollipara
,
R. K. Lord
,
O. Oluola
Journal of Perinatology
2013
Corpus ID: 6130998
Congenital cytomegalovirus (CMV) infection is a major cause of birth defects and childhood disorders in the United States…
Expand
2006
2006
Treatment of cytomegalovirus retinitis with intravitreal ganciclovir: a case report
O. Edema
,
A. Rutzen
2006
Corpus ID: 70631531
A 60-year-old male on chemotherapy for multiple myeloma developed cytomegalovirus (CMV) retinitis in one eye. He was commenced on…
Expand
2003
2003
Ganciclovir release rates in vitreous from different formulations of 1-O-hexadecylpropanediol-3-phospho-ganciclovir.
Lingyun Cheng
,
K. Hostetler
,
+6 authors
W. Freeman
Journal of Ocular Pharmacology and Therapeutics
2003
Corpus ID: 1300269
PURPOSE To determine the optimal formulation of lipid prodrug, 1-O-hexadecyloxypropyl-phospho-ganciclovir (HDP-P-GCV), for…
Expand
2002
2002
Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.
Lingyun Cheng
,
K. Hostetler
,
+5 authors
W. Freeman
Investigative Ophthalmology and Visual Science
2002
Corpus ID: 17250543
PURPOSE To evaluate an intraocular drug delivery system consisting of the crystalline ammonium salt of 1-O-hexadecylpropanediol-3…
Expand
1996
1996
[Intravitreal ganciclovir in cytomegalovirus retinitis in AIDS].
J. L. Olea
,
M. Salvat
,
J. Mateos
,
J. Vila
,
C. Villalonga
,
M. Riera
Revista clínica española (Ed. impresa)
1996
Corpus ID: 26428275
A retrospective study was made of 26 patients with AIDS who initially presented with retinitis as the only clinical manifestation…
Expand
1996
1996
Intravitreal Ganciclovir for Cytomegalovirus Retinitis in Patients with AIDS
M. C. Montero
,
M. Pastor
,
Catalina Buenestado
,
A. Lluch
,
M. Atienza
The Annals of Pharmacotherapy
1996
Corpus ID: 32890527
OBJECTIVE: To assess the evolution of cytomegalovirus (CMV) retinitis and evaluate the possible complications associated with the…
Expand
1994
1994
High-performance liquid chromatographic determination of ganciclovir nucleotides in human myocardial tissue.
N. Bleyzac
,
R. Boulieu
Journal of chromatography. B, Biomedical…
1994
Corpus ID: 33513752
1994
1994
Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice
D. Smee
,
S. Sugiyama
,
E. J. Reist
Antimicrobial Agents and Chemotherapy
1994
Corpus ID: 1501724
Acyclovir phosphonate [9-(3-phosphono-propyloxymethyl)guanine; SR3722] and the S enantiomer (SR3772), R enantiomer (SR3773), and…
Expand
1994
1994
Structure and conformation of the cyclic phosphate of Ganciclovir, a broad-spectrum antiviral agent.
K. B. Birnbaum
,
R. Stolarski
,
D. Shugar
Biochimica et Biophysica Acta
1994
Corpus ID: 9354553
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required